Welcome to Markets Desk, your midday read on what's moving markets and the world behind them.
CStone Pharmaceuticals is trading higher in Hong Kong after announcing a clinical collaboration with Kimia Therapeutics to develop a compound targeting the DNA damage response pathway in solid tumours. CStone will lead the clinical program, and investors are reading the deal as a meaningful pipeline expansion in oncology.
Shifting to medical devices, Smith and Nephew posted higher third-quarter revenues with growth across all regions, but the British medtech firm cut its fiscal two thousand twenty six guidance, citing slower-than-expected performance in its orthopaedics division. The company says it continues to explore strategic options for that unit, which signals a potential divestiture or restructuring could be on the table.
And in banking, AIB Group reported nine-month net interest income of two point eight seven billion euros, up two percent year over year on the back of higher average lending volumes. Third-quarter net interest income hit one billion euros, and the Irish lender upgraded its full-year two thousand twenty six guidance, reflecting confidence in continued volume-driven margin support.
That's the tape. Markets Desk, signing off the floor.
